Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for clinical trial business management.
Strategikon Pharma has raised $2.3M in total funding. The most recent round was Debt Financing. The last funding was announced in June 2025.
Strategikon Pharma's investors include Alumni Ventures, Wing Venture Capital, Osage Venture Partners, Golden Seeds, Decathlon Capital Partners.
Strategikon Pharma is headquartered in San Rafael, United States.
Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for clinical trial business management.
Strategikon Pharma is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Strategikon Pharma — Funding & Investors." VCBacked, June 10, 2025, https://www.vcbacked.co/company/strategikon-pharma. Accessed September 30, 2026.
VCBacked. (2025). Strategikon Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/strategikon-pharma
{{cite web |title=Strategikon Pharma — Funding & Investors |url=https://www.vcbacked.co/company/strategikon-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated